Pancreatic Cell News Volume 14.17 | May 9 2023

    0
    36








    2023-05-09 | PACN 14.17


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 14.17 – 9 May, 2023
    TOP STORY

    Sirtuin 6 Is Required for the Integrated Stress Response and Resistance to Inhibition of Transcriptional Cyclin-Dependent Kinases

    The authors found that basal PDACs were uniquely sensitive to transcriptional inhibition by targeting cyclin-dependent kinase 7 (CDK7) and CDK9, and this sensitivity was recapitulated in the basal subtype of breast cancer.
    [Science Translational Medicine]

    Abstract
    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    PUBLICATIONSRanked by the impact factor of the journal

    USP7 Controls NGN3 Stability and Pancreatic Endocrine Lineage Development

    Investigators screened for binding partners of neurogenin 3 (NGN3) and identified the deubiquitylating enzyme ubiquitin-specific peptidase 7 (USP7) as a key regulator of NGN3 stability.
    [Nature Communications]

    Full Article

    Upregulation of the ERRγ–VDAC1 Axis Underlies the Molecular Pathogenesis of Pancreatitis

    Scientists demonstrated in both mice models and human cohorts that pancreatitis was associated with an increase in estrogen-related receptor γ (ERRγ) gene expression via activation of STAT3.
    [Proceedings Of The National Academy Of Sciences Of The United States Of America]

    Abstract

    Differentiation of Stem Cell-Derived Pancreatic Progenitors into Insulin-Secreting Islet Clusters in a Multiwell-Based Static 3D Culture System

    Researchers described a 96-well-based static suspension culture method for differentiation of pancreatic progenitors into human pluripotent stem cell-islets.
    [Cell Reports Methods]

    Full ArticleGraphical Abstract

    Pancreatic β-Cell Glutaminase 2 Maintains Glucose Homeostasis under the Condition of Hyperglycaemia

    To investigate the roles of glutaminase 2 (GLS2) in pancreatic β-cells in vivo, the authors generated β-cell-specific Gls2 conditional knockout mice, examined their glucose homeostasis, and validated the findings using a human islet single-cell analysis database.
    [Scientific Reports]

    Full Article

    Cell-Selective Proteomics Segregates Pancreatic Cancer Subtypes by Extracellular Proteins in Tumors and Circulation

    Researchers devised a comprehensive azidonorleucine labeling, click chemistry enrichment, and mass spectrometry-based proteomics and secretomics strategy to dissect aberrant signals in PDAC.
    [Nature Communications]

    Full Article

    Targeting MFAP5 in Cancer-Associated Fibroblasts Sensitizes Pancreatic Cancer to PD-L1-Based Immunochemotherapy via Remodeling the Matrix

    Scientists found that prognostic microfibril associated protein 5 (MFAP5) was involved in activation of cancer-associated fibroblasts (CAFs). CAFs derived from both human and mouse PDAC tumors were isolated and cultured.
    [Oncogene]

    Full Article

    KMT2D Links TGF-β Signaling to Noncanonical Activin Pathway and Regulates Pancreatic Cancer Cell Plasticity

    Using in vitro and in vivo models, the authors showed that KMT2D silencing was mediated by transforming growth factor-β (TGF-β) upregulation of microRNA-147b.
    [International Journal of Cancer]

    Full ArticleGraphical Abstract

    Agrimoniin Is a Dual Inhibitor of AKT and ERK Pathways That Inhibit Pancreatic Cancer Cell Proliferation

    Researchers used 5-ethynyl-2′-deoxyuridine, cell counting kit-8, flow cytometry, and western blot experiments to confirm that agrimoniin could significantly inhibit the proliferation of pancreatic cancer cell PANC-1 by inducing apoptosis and cell cycle arrest.
    [Phytotherapy Research]

    Abstract
    On-demand Webinar on Studying Cystic Fibrosis using Primary Human Nasal Epithelial Cells - Watch Now
    REVIEWS

    Developments in Stem Cell-Derived Islet Replacement Therapy for Treating Type 1 Diabetes

    Scientists highlight the most recent advances in the generation and characterization of highly functional stem cell islets as well as strategies to ensure graft viability and safety after transplantation.
    [Cell Stem Cell]

    Full Article
    INDUSTRY AND POLICY NEWS

    Radiopharm Theranostics Receives FDA Orphan Drug Designation for Trivehexin (RAD 301) in Pancreatic Cancer

    Radiopharm Theranostics announced that the US FDA has granted Orphan Drug Designation to Ga68-Trivehexin, RAD 301, radiopharmaceutical technology for imaging of patients with PDAC.
    [Radiopharm Theranostics]

    Press Release
    FEATURED EVENT

    The 2023 ASCO Annual Meeting

    June 2 – 6, 2023
    Chicago, Illinois, United States

    > See All Events

    JOB OPPORTUNITIES

    Professorships – Cell Physiology and Metabolism

    University of Geneva – Geneva, Switzerland

    Postdoctoral Fellow – Stem Cell and Regenerative Medicine

    Weill Cornell Medical College – New York, New York, United States

    Postdoctoral Research Fellow Position – Pancreatic Cancer Metabolism

    The University of Oklahoma Health Sciences Center – Oklahoma City, Oklahoma, United States

    Postdoctoral Research Associate – Oncology

    St. Jude Children’s Research Hospital – Memphis, Tennessee, United States

    Postdoctoral Researcher – Pancreatic Cancer

    UNMC Pancreatic Cancer Center of Excellence – Omaha, Nebraska, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter